Previous 10 | Next 10 |
2024-01-08 16:07:34 ET More on Accolade Accolade: Multiples Should Rerate As ACCD Continues To Execute Accolade Q3 2024 Earnings Preview Accolade announces repurchase of $76.5M of 0.50% convertible senior notes due 2026 Seeking Alpha’s Quant Rating on ...
SEATTLE, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023. “As we head into the new year, Accolade continues to define the future of how healthcare should be experienced in this...
SeaChange International Inc. (SEAC) is expected to report for quarter end 2023-10-31 Helen of Troy Limited (HELE) is expected to report $2.46 for Q3 2024 Commercial Metals Company (CMC) is expected to report $1.43 for Q1 2024 Pure Cycle Corporation (PCYO) is expected to report for Q1 ...
2024-01-07 08:39:00 ET The upcoming week heralds the commencement of earnings season, featuring major players from the financial, consumer, and industrial sectors poised to unveil their quarterly financial results. For further details see: Earnings week ahead: Citigroup, JPMorgan, U...
2024-01-06 17:35:06 ET ACCD , JEF For Seeking Alpha's full earnings season calendar, click here . For further details see: Notable earnings after Monday's close
SEATTLE, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2024 financial results on Monday, January 8, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T...
2023-12-07 17:09:39 ET Gainers: Grayscale Solana Trust ( OTCQB:GSOL ) +7% . Accolade ( ACCD ) +5% . TPI Composites ( TPIC ) +5% . Travere Therapeutics ( TVTX ) +4% . 1-800-FLOWERS ( FLWS ) +3% . Losers: HashiCorp ( HCP ...
SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Piper Sandler 35 th Annual Healthcare Conference in New York on Wednesday, November 29, 2023 at 10:00 am ET. ...
2023-11-19 08:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-16 16:08:42 ET More on Accolade Accolade: Multiples Should Rerate As ACCD Continues To Execute Obesity drug coverage among U.S. employers to nearly double in 2024: survey Accolade FQ2 2024 Earnings Preview For further details see: Accolade announc...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...